COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2581-5555

Online ISSN:-2456-9542


Current Issue

Year 2020

Volume: 5 , Issue: 1

Article Access statistics

Viewed: 230

Emailed: 0

PDF Downloaded: 81

IP International Journal of Comprehensive and Advanced Pharmacology

Efficacy and cost effectiveness comparision between fusidic acid and mupirocin for impetigo

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Fazeel Zubair Ahmed*, Anusharani M V

Volume : 4, Issue : 3, Year : 2019

Article Page : 100-104

Suggest article by email


Introduction: Impetigo is a contagious skin infection due to S. aureus or S. pyogenes that usually affects children. BNF recommends topical fusidic acid or mupirocin for impetigo. This study compares the efficacy and cost-effectiveness of topical fusidic acid and mupirocin in treatment of impetigo.
Materials and Methods: This was an open label, prospective study done on 100 impetigo patients attending OPD of Viswabharathi General & Teaching Hospital, Kurnool, Andhra Pradesh, India from January 2016 to December 2016. The primary end points were evaluated at the baseline, and after one week of treatment. The end points were: number of lesions, size of the lesions, SSI score and cost to treat a single case. Patients were randomly allocated to two groups – fusidic acid group and mupirocin group. In both groups the test drug was applied locally thrice daily. Statistical analysis was done using student’s paired t test and unpaired t test. p-value of <0>
Results: In fusidic acid group; number of lesions declined from 4.24±1.17 to 0.24±0.82, wound area (cm2) decreased from 3.24±0.95 to 0.34±1.18 and SSI decreased from 2.32±0.47 to 0.14±0.49. While in mupirocin group; number of lesions declined from 4.16±1.11 to 0.14±0.70, wound area (cm2) decreased from 3.45±1.14 to 0.17±0.85 and SSI decreased from 2.44±0.50 to 0.08±0.39. All these changes were statistically significant. Cost to treat one case was INR 46 for fusidic acid and INR 72 for mupirocin.
Conclusion: Mupirocin is marginally more effective than fusidic acid but this difference was not statistically significant. Cost effectiveness of fusidic acid is less than mupirocin.

Keywords: Fusidic acid, Mupirocin, Impetigo, Cost-effectiveness, Efficacy, Comparison.

Doi : 10.18231/j.ijcaap.2019.021

How to cite : Ahmed F Z, Anusharani M V, Efficacy and cost effectiveness comparision between fusidic acid and mupirocin for impetigo. IP Int J Compr Adv Pharmacol 2019;4(3):100-104

Copyright © 2019 by author(s) and IP Int J Compr Adv Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (